Track Narayana Hrudayalaya Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -2.13 %
Low
1,850.5
High
1,941.3
1 Month returns: 0.65 %
Low
1,780.0
High
1,949.6
1 Year returns: 6.35 %
Low
1,564.3
High
2,094.3
3 Year CAGR: 23.31 %
Low
980.0
High
2,371.6
5 Year CAGR: 29.18 %
Low
491.9
High
2,371.6
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Narayana Hrudayalaya Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Narayana Hrudayalaya Ltd. Shareholding Pattern
Quarterly breakdown of Narayana Hrudayalaya Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Narayana Hrudayalaya Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Narayana Hrudayalaya Ltd.?
The current share price of Narayana Hrudayalaya Ltd. is ₹ 1,897.40 as of 8 Sep 2026.
What is the market capitalisation of Narayana Hrudayalaya Ltd.?
The market capitalisation of Narayana Hrudayalaya Ltd. stands at ₹ 38,536.20 Cr.
What is the PE ratio of Narayana Hrudayalaya Ltd.?
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd. is 47.22 as of the latest trailing twelve months data.
What is the ROE and ROCE of Narayana Hrudayalaya Ltd.?
Narayana Hrudayalaya Ltd. has a Return on Equity (ROE) of 19.09% and a Return on Capital Employed (ROCE) of 14.18% as per the latest financial reports.
What is the 52-week high and low of Narayana Hrudayalaya Ltd.?
The 52-week high of Narayana Hrudayalaya Ltd. is - and the 52-week low is -.
What is the dividend yield of Narayana Hrudayalaya Ltd.?
The dividend yield of Narayana Hrudayalaya Ltd. is 0.24% based on the current market price.
What is the FII and DII holding in Narayana Hrudayalaya Ltd.?
Foreign Institutional Investors (FII) hold 9.40%, Domestic Institutional Investors (DII) hold 8.00% and retail/public investors hold 16.39% of Narayana Hrudayalaya Ltd. shares.
What sector does Narayana Hrudayalaya Ltd. belong to?
Narayana Hrudayalaya Ltd. operates in the Healthcare sector. 90% of analysts have a Buy or Strong Buy rating on Narayana Hrudayalaya Ltd. with a consensus target price of ₹ 2,150.00, implying 13.31% upside from current levels.
What is the beta of Narayana Hrudayalaya Ltd.?
The beta of Narayana Hrudayalaya Ltd. is 0.71, indicating its price volatility relative to the broader market. Over the past 1 year, Narayana Hrudayalaya Ltd. has delivered an absolute return of 7.38%.
What is the RSI of Narayana Hrudayalaya Ltd.?
The 14-day Relative Strength Index (RSI) of Narayana Hrudayalaya Ltd. is 50.29, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.27
63.27
63.27
Indian Promoter
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.85
63.27
63.27
63.27
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
29.02
29.24
29.63
30.13
30.55
30.17
30.37
29.76
28.98
27.88
26.17
24.81
24.50
23.05
22.49
21.74
20.43
18.25
17.58
18.13
18.18
18.55
18.25
19.01
19.13
18.46
Mutual Funds / UTI
13.93
14.55
16.27
15.55
14.79
15.55
16.15
14.61
13.76
13.43
13.20
11.75
10.87
9.08
8.20
7.89
7.18
5.99
4.47
5.54
5.71
5.54
5.29
6.22
7.24
7.34
FI/Bank/Insurance
0.14
0.06
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.98
2.27
2.69
2.01
1.93
1.57
1.27
0.92
2.03
2.04
1.70
1.51
1.45
0.63
0.79
0.66
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0.01
0.01
-
-
-
-
-
-
-
-
FII
9.58
9.28
8.54
8.95
10.96
10.12
10.74
10.80
10.64
10.03
9.55
10.24
10.36
11.10
11.59
11.51
10.91
10.02
9.69
9.45
9.66
10.46
10.49
11.10
9.98
9.40
Other Institutions
5.37
9.43
4.82
5.62
4.80
4.50
5.85
7.90
8.74
8.55
0.44
0.56
0.58
0.86
0.76
0.77
1.06
1.31
1.40
1.10
1.11
1.04
1.02
1.06
1.11
1.05
Non-Institution
7.13
6.90
6.52
6.03
5.60
5.98
5.78
6.39
7.17
8.28
9.97
11.33
11.64
13.09
13.66
14.41
15.73
17.91
18.57
18.02
17.97
17.60
17.90
17.72
17.60
18.27
Bodies Corporate
-
-
-
-
-
-
-
0.13
0.24
0.34
0.65
0.83
0.89
0.99
1.01
1.08
1.28
1.57
1.57
1.48
1.45
1.41
1.45
1.48
1.51
1.88
Others (incl. Retail)
No. of shareholders
7.13
34,321
6.90
34,780
6.52
32,679
6.03
31,206
5.60
36,119
5.98
44,240
5.78
43,275
6.26
43,489
6.93
52,195
7.94
64,420
9.32
67,212
10.50
72,149
10.75
74,324
12.10
85,470
12.65
1,01,701
13.33
1,19,090
14.45
1,36,420
16.34
1,58,943
17.00
1,76,551
16.54
1,76,109
16.52
1,83,932
16.19
2,03,692
16.45
2,24,505
16.24
2,26,186
16.09
2,18,703
16.39
2,09,378
Company Profile
Overview of Narayana Hrudayalaya Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental and behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of over 18 hospitals and three heart centers across India, along with an international presence in the Cayman Islands.
Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiolo...
Key personnel
Ms. Sandhya Jayaraman
Group Chief Financial Officer
Mr. Sridhar Seshiah
Group Company Secretary, Legal and Compliance Officer
Dr. Devi Prasad ShettyD
Executive Chairman of the Board, Whole Time Director
Dr. Emmanuel RupertD
Group Chief Executive Officer, Managing Director, Executive Director
Fundamental analysis overview of Narayana Hrudayalaya Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 60.59% for 12-month ended 30 Jun 2026 and the growth was 42.51 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 18.08
Value 60.59
-26.8103.8
Negative
Expensive and at same valuation levels as industry median P/E
PE TTM of 47.22 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -8.38%
What is P/E Ratio?
Median: 51.54
Value 47.22
14.881568.41
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -2.51% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Moderate operating margin but declining trend
The company reported moderate operating margin of 13.56% for 12-month ended 30 Jun 2026 but operating margin declined by -430 bps from 1 year ago
What is Operating profit margin?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of 4.85% for 12-month ended 30 Jun 2026 and the growth was 7.28 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Reasonable Debt to Equity, but increasing
The company has reasonable Debt to Equity of 1.25 as on 30 Jun 2026 but Debt to Equity increased by 0.61 in the last 1 year
What is Debt to Equity?
Low dividend yield
The company has a low dividend yield of 0.24%
What is Dividend yield?
Neutral
High ROE but declining trend
The company reported strong ROE of 19.09% for 12-month ended 30 Jun 2026 but ROE declined by -421 bps from 1 year ago
What is ROE (FY)?
Company's earnings are of moderate quality
Earnings quality score of 59.9 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
59.9 / 100
No red flags found!
No significant red flags found in the stock.
Holdings and Presence
Indices and prominent investors with a stake in this stock.